Implementation of the Management of Anticoagulation in the Periprocedural Period App into an Electronic Health Record: A Cost-Effectiveness Analysis
Open Access
- 1 January 2023
- journal article
- research article
- Published by SAGE Publications in Clinical and Applied Thrombosis/Hemostasis
- Vol. 29
Abstract
The Management of Anticoagulation in the Periprocedural Period (MAPPP) app is a free tool providing up-to-date guidelines on the periprocedural management of patients on long-term anticoagulants. After validating its effectiveness in the post-procedural period, we aimed to study its overall cost-effectiveness. SF-12 surveys were sent to eligible patients, converted into SF-6D forms, and subsequently into quality-adjusted life years (QALYs) to calculate the incremental cost-effectiveness ratio (ICER). The number of 30-day readmissions was used to calculate hospitalization costs, utilizing publicly available data. From 1/1/2018 to 1/31/2019, 642 patients were screened for enrollment, with an overall response rate of 94% (164/175) among the consented and 49% (164/336) among all eligible patients. The average QALY score was 0.7134 (95% CI [0.6836, 0.7431]) for the patients whose treatment plan followed the MAPPP app recommendations (acceptance group) and 0.7104 (95% CI [0.6760, 0.7448]) for those who did not (rejection group), without statistically significant differences. The difference in ICER scores was −$429 866.67, with the negative sign demonstrating that acceptance was the dominant strategy. By utilizing QALYs and ICER scores we have shown that the acceptance of MAPPP app recommendations is the dominant strategy for the periprocedural management of patients on long-term anticoagulation.Keywords
This publication has 15 references indexed in Scilit:
- The Cost-Effectiveness of Digital Health Interventions on the Management of Cardiovascular Diseases: Systematic ReviewJournal of Medical Internet Research, 2019
- Frequency of hospital readmissions for venous thromboembolism and associated hospital costs and length of stay among acute medically ill patients in the USJournal of Medical Economics, 2019
- Uptake and Utilization of the Management of Anticoagulation in the Periprocedural Period App: Longitudinal AnalysisJMIR mHealth and uHealth, 2018
- Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness AnalysesJAMA, 2016
- Thrombosis: A major contributor to global disease burdenThrombosis Research, 2014
- Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort studyBMJ, 2009
- Interpreting the Results of Cost-Effectiveness StudiesJACC, 2008
- Modelling SF-6D health state preference data using a nonparametric Bayesian methodJournal of Health Economics, 2007
- The Estimation of a Preference-Based Measure of Health From the SF-12Medical Care, 2004
- The estimation of a preference-based measure of health from the SF-36Journal of Health Economics, 2002